Publicaciones en colaboración con investigadores/as de Instituto de Investigaciones Biomédicas Alberto Sols (279)

2024

  1. Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia

    Antioxidants, Vol. 13, Núm. 9

  2. Beneficial effects of hepatic cyclooxygenase-2 expression against cholestatic injury after common bile duct ligation in mice

    Liver International, Vol. 44, Núm. 9, pp. 2409-2423

  3. Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New Perspective

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

  4. Contribution of Nucleotide-Binding Oligomerization Domain-like (NOD) Receptors to the Immune and Metabolic Health

    Biomedicines, Vol. 12, Núm. 2

  5. Crosstalk between P2Y receptors and cyclooxygenase activity in inflammation and tissue repair

    Purinergic Signalling, Vol. 20, Núm. 2, pp. 145-155

  6. Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  7. GDF15 activates AMPK and inhibits gluconeogenesis and fibrosis in the liver by attenuating the TGF-β1/SMAD3 pathway

    Metabolism: Clinical and Experimental, Vol. 152

  8. PPARβ/δ attenuates hepatic fibrosis by reducing SMAD3 phosphorylation and p300 levels via AMPK in hepatic stellate cells

    Biomedicine and Pharmacotherapy, Vol. 179

  9. Percutaneous pulmonary thrombectomy with aspiration catheters in patients with high-risk pulmonary embolism and absolute contraindication to systemic thrombolysis

    Cardiovascular Revascularization Medicine

  10. Potential protective role of let-7d-5p in atherosclerosis progression reducing the inflammatory pathway regulated by NF-κB and vascular smooth muscle cells proliferation

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1870, Núm. 7

  11. The hepatocyte epidermal growth factor receptor (EGFR) pathway regulates the cellular interactome within the liver fibrotic niche

    Journal of Pathology, Vol. 263, Núm. 4-5, pp. 482-495

  12. Trabectedin and Lurbinectedin Modulate the Interplay between Cells in the Tumour Microenvironment—Progresses in Their Use in Combined Cancer Therapy

    Molecules, Vol. 29, Núm. 2

2023

  1. Beneficial effect of TLR4 blockade by a specific aptamer antagonist after acute myocardial infarction

    Biomedicine and Pharmacotherapy, Vol. 158

  2. Circulating bone morphogenetic protein 8A is a novel biomarker to predict advanced liver fibrosis

    Biomarker Research, Vol. 11, Núm. 1

  3. Correction to: Nanomedicine for autophagy modulation in cancer therapy: a clinical perspective (Cell & Bioscience, (2023), 13, 1, (44), 10.1186/s13578-023-00986-9)

    Cell and Bioscience

  4. Defining the metabolic signatures associated with human macrophage polarisation

    Biochemical Society transactions, Vol. 51, Núm. 4, pp. 1429-1436

  5. Effect of rapamycin on lysosomal accumulation in a CRISPR/Cas9-based cellular model of VPS13A deficiency

    Journal of Cellular and Molecular Medicine, Vol. 27, Núm. 11, pp. 1557-1564

  6. Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ

    Biomedicine and Pharmacotherapy, Vol. 167

  7. Hypothalamic JNK1-hepatic fatty acid synthase axis mediates a metabolic rewiring that prevents hepatic steatosis in male mice treated with olanzapine via intraperitoneal: Additional effects of PTP1B inhibition

    Redox Biology, Vol. 63

  8. Immunometabolic actions of trabectedin and lurbinectedin on human macrophages: relevance for their anti-tumor activity

    Frontiers in Immunology, Vol. 14